专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明申请

US20120044149A1 MISINPUT AVOIDANCE METHOD FOR MOBILE TERMINAL 审中-公开
标题翻译：移动终端的MISINPUT避免方法
公开(公告)号：US20120044149A1
公开(公告)日：2012-02-23
申请号：US13213926
申请日：2011-08-19
申请人： Dong Kyun Son , Dong Han Kang , Woo Chan Park , Jong Soo Woo , Sang Hoon Kang
发明人： Dong Kyun Son , Dong Han Kang , Woo Chan Park , Jong Soo Woo , Sang Hoon Kang
IPC分类号： G06F3/023
CPC分类号： G06F3/023
摘要： A misinput avoidance method of a mobile terminal may be implemented to prevent a misinput caused by contacting unintended keys around the target key. A misinput avoidance method of a mobile terminal according to the present invention includes detecting inputs of a plurality of keys and discriminating a target key from other keys. The method also includes extracting keys around the target key and registering the keys around the target keys as neighbor keys. The method further includes processing the input of the target key while blocking the inputs of the neighbor keys. The method further includes releasing, when the target key is released, the blocking of the inputs of the neighbor keys.
摘要翻译：可以实现移动终端的误输入回避方法，以防止由于围绕目标密钥接触意外的密钥造成的误输。根据本发明的移动终端的误输入回避方法包括检测多个密钥的输入并且将目标密钥与其他密钥相区别。该方法还包括提取围绕目标密钥的密钥并将目标密钥周围的密钥注册为相邻密钥。该方法还包括处理目标密钥的输入，同时阻挡相邻密钥的输入。该方法还包括当目标密钥被释放时释放邻居密钥的输入的阻塞。

22. 发明申请

US20080292702A1 Solid Dispersion Comprising An Active Ingredient Having A Low Melting Point And Tablet For Oral Administration Comprising Same 审中-公开
标题翻译：具有低熔点的活性成分的固体分散体和包含其的口服给药片剂
公开(公告)号：US20080292702A1
公开(公告)日：2008-11-27
申请号：US12097299
申请日：2006-12-18
申请人： Jong Soo Woo , Sang Wook Kim , Hong Gi Yi , Jae Kuk Ryu
发明人： Jong Soo Woo , Sang Wook Kim , Hong Gi Yi , Jae Kuk Ryu
IPC分类号： A61K9/24 , A61K31/192 , A61K47/38 , A61K47/36 , A61K47/02 , A61K47/32 , A61K9/22
CPC分类号： A61K9/143 , A61K9/145 , A61K9/2054 , A61K9/209
摘要： A fused solid dispersion comprising an active ingredient having a melting point of 800 C or below and a pharmaceutically acceptable absorbent having a specific surface area ranging from 20 to 400 mVg can be conveniently compressed into a tablet without generating capping and sticking problems, and a tablet comprising said fused solid dispersion can maintain an uniform release rate over a prolonged time when orally administered.
摘要翻译：包含熔点为800℃以下的活性成分的熔融固体分散体和比表面积为20〜400m 2 / g的药学上可接受的吸收剂可以方便地压缩成片剂而不产生封盖和粘附问题，并将片剂包含所述熔融固体分散体在口服给药时可以在延长的时间内保持均匀的释放速率。

23. 发明授权

US06451128B1 Method for manufacturing high magnetic flux denshy grain oriented electrical steel sheet based on low temperature slab heating method 有权
标题翻译：基于低温板坯加热方法制造高磁通密度晶粒取向电工钢板的方法
公开(公告)号：US06451128B1
公开(公告)日：2002-09-17
申请号：US09242865
申请日：1999-02-25
申请人： Chung San Lee , Chan Hye Han , Jong Soo Woo , Gyu Seung Choi , Jae Kwan Kim , Byung Deuk Hong , Kyu Seok Han
发明人： Chung San Lee , Chan Hye Han , Jong Soo Woo , Gyu Seung Choi , Jae Kwan Kim , Byung Deuk Hong , Kyu Seok Han
IPC分类号： H01F1147
CPC分类号： C21D3/04 , C21D8/1255 , C21D8/1272
摘要： A method for manufacturing a high magnetic flux density grain oriented electrical steel sheet is disclosed. A silicon steel slab is heated and hot-rolled, and the steel sheet is annealed and cold-rolled and decarburized. An annealing separator is spread on the steel sheet, and a final high temperature annealing is carried out. The silicon steel contains in weight % 0.02-0.045% of C, 2.90-3.30% of Si, 0.05-0.30% of Mn, 0.005-0.019% of Al, 0.003-0.008% of N, 0.006% or less of S (the above being main ingredients), 0.001-0.012% of B, and a balance of Fe and unavoidable impurities; or the above main ingredients plus 0.30-0.70% of Cu, 0.03-0.07% of Ni, 0.03-0.07% of Cr, and a balance of Fe and unavoidable impurities; or the above main ingredients plus 0.001-0.012% of B, 0.30-0.70% of Cu, 0.03-0.07% of Ni, 0.03-0.07% of Cr, and a balance of Fe and unavoidable impurities.
摘要翻译：公开了一种制造高磁通密度晶粒取向电工钢板的方法。对硅钢板进行加热热轧，对钢板进行退火冷轧，脱碳。将退火分离器铺展在钢板上，进行最终的高温退火。硅钢的重量％为C：0.02-0.045％，Si：2.90-3.30％，Mn：0.05-0.30％，Al：0.005-0.019％，N：0.003-0.008％，S：0.006％以上为主要成分），0.001-0.012％B，余量为Fe和不可避免的杂质; 或上述主要成分加入Cu 0.30-0.70％，Ni 0.03-0.07％，Cr 0.03-0.07％，余量为Fe和不可避免的杂质; 或上述主要成分加上0.001-0.012％的B，0.30-0.70％的Cu，0.03-0.07％的Ni，0.03-0.07％的Cr，余量的Fe和不可避免的杂质。

24. 发明授权

US5803988A Method for manufacturing non-oriented electrical steel sheet showing superior adherence of insulating coated layer 失效
标题翻译：制造无取向电工钢板的方法，其表现出优异的绝缘涂层粘附性
公开(公告)号：US5803988A
公开(公告)日：1998-09-08
申请号：US894394
申请日：1997-08-18
申请人： Byung Keun Bae , Sam Kyu Chang , Jong Soo Woo , Wun Gul Lee
发明人： Byung Keun Bae , Sam Kyu Chang , Jong Soo Woo , Wun Gul Lee
IPC分类号： C21D3/04 , C21D8/12 , C22C38/02 , H01F1/147 , H01F1/18
CPC分类号： C21D8/1288 , C21D8/1272 , C21D8/1277 , H01F1/147 , H01F1/18 , C21D3/04
摘要： The annealing conditions of a cold rolled steel sheet are properly controlled so as to form a dense surface oxide layer, thereby improving the adherence strength of the insulating layer on non-oriented electrical steel sheet. The method includes the following steps. A steel slab is prepared which is composed of in weight %: 0.05% or less of C, 3.5% or less of Si, 1.5% or less of Mn, 0.15% or less of P, 0.015% or less of S, 1.0% or less of Al, one or more elements selected from a group consisting of 0.03-0.30% of Sn, 0.03-0.3% of Sb, 0.03-1.0% of Ni and 0.03-0.50% of Cu, the balance of Fe and unavoidable impurities. The steel slab is reheated, hot rolled, pickled after annealing or without annealing and cold-rolled. A low temperature annealing is carried out on the cold rolled steel sheet at a temperature of 750.degree.-850.degree. C. for 30 seconds to 5 minutes under a humid atmosphere having a dew point of 25.degree.-65.degree. C. A high temperature annealing is carried out on the low-temperature-annealed cold rolled steel sheet at a temperature of 800.degree.-1070.degree. C. for 10 seconds to 3 minutes under a dry atmosphere having a dew point of 0.degree. C. or below. Insulating layers are coated on the surfaces of the high-temperature-annealed steel sheet, and a hardening heat treatment is carried out on the steel sheet.
摘要翻译： PCT No.PCT / KR96 / 00078 Sec。 371日期：1997年8月18日 102（e）1997年8月18日PCT PCT 1996年6月1日PCT公布。公开号WO97 / 22723 日期1996年6月26日冷轧钢板的退火条件被适当地控制，以形成致密的表面氧化物层，从而提高无取向电工钢板上的绝缘层的粘附强度。该方法包括以下步骤。制备钢板，其重量％：C：0.05％以下，Si：3.5％以下，Mn：1.5％以下，P：0.15％以下，S：0.015％以下，1.0％或更少的Al，一种或多种选自Sn，0.03-0.30％的Sn，0.03-0.3％的Sb，0.03-1.0％的Ni和0.03-0.50％的Cu，其余的Fe和不可避免的杂质。再次加热，热轧，退火或不退火冷轧后酸洗。在露点为25〜-65℃的潮湿气氛下，在750〜-850℃的温度下对冷轧钢板进行低温退火30秒〜5分钟。高温退火在露点为0℃以下的干燥气氛下，在800〜-1070℃的温度下在低温退火冷轧钢板上进行10秒钟〜3分钟。在高温退火钢板的表面上涂布绝缘层，对钢板进行硬化热处理。

25. 发明申请

US20100003289A1 Controlled Release Complex Formulation For Oral Administration of Medicine For Diabetes and Method For The Preparation Thereof 审中-公开
标题翻译：糖尿病口服药物控释制剂及其制备方法
公开(公告)号：US20100003289A1
公开(公告)日：2010-01-07
申请号：US11722560
申请日：2005-12-28
申请人： Jong Soo Woo , Hong Gi Yi , Moon Hyuk Chi , Young Hun Kim
发明人： Jong Soo Woo , Hong Gi Yi , Moon Hyuk Chi , Young Hun Kim
IPC分类号： A61K9/00 , A61K31/155 , A61K31/40 , A61P3/10
CPC分类号： A61K31/155 , A61K9/209 , A61K31/64 , A61K45/06 , A61K2300/00
摘要： A controlled release combination formulation for oral administration comprising a) a controlled release portion containing metformin or a pharmaceutically acceptable salt thereof as an active ingredient, and a combination of a polyethylene oxide and a natural gum as a carrier for controlled release; and b) a rapid-release portion containing a sulfonylurea-based medicine for treating diabetes as an active ingredient coated on the controlled release portion is useful for the treatment of diabetes, for it is capable of maintaining an effective concentration of the medicines in blood at a constant level.
摘要翻译：一种用于口服给药的控释组合制剂，其包含a）含有二甲双胍或其药学上可接受的盐作为活性成分的受控释放部分，以及作为受控释放的载体的聚环氧乙烷和天然树胶的组合; 和b）包含用于治疗糖尿病作为包被在控制释放部分上的活性成分的磺酰脲类药物的快速释放部分可用于治疗糖尿病，因为它能够维持血液中药物的有效浓度一个恒定的水平。

26. 发明申请

US20090042952A1 Sustained Release Composition for Oral Administration of Niacin 失效
标题翻译：烟酸口服给药缓释组合物
公开(公告)号：US20090042952A1
公开(公告)日：2009-02-12
申请号：US11569269
申请日：2005-05-27
申请人： Jong Soo Woo , Young Hun Kim
发明人： Jong Soo Woo , Young Hun Kim
IPC分类号： A61K31/4406
CPC分类号： A61K31/44 , A61K9/2027 , A61K9/2031 , A61K9/205 , A61K9/2077
摘要： A sustained release composition for oral administration of niacin, comprising niacin; a carrier for sustained release composed of a hydrophilic polymer and a hydrophobic polymer; and a pharmaceutically acceptable additive, the hydrophilic polymer being a polyethylene oxide and a natural gum, is capable of maintaining a constant release rate of niacin.
摘要翻译：口服烟酸的持续释放组合物，其包含烟酸; 由亲水性聚合物和疏水性聚合物组成的持续释放载体; 和药学上可接受的添加剂，亲水性聚合物是聚环氧乙烷和天然树胶，能够保持烟酸的恒定释放速率。

27. 发明申请

US20080153866A1 Amorphous Taclolimus Solid Dispersion Having an Enhanced Solubility and Pharmaceutical Composition Comprising Same 审中-公开
标题翻译：具有增强的溶解度和药物组合物的无定形Taclolimus固体分散体
公开(公告)号：US20080153866A1
公开(公告)日：2008-06-26
申请号：US11815345
申请日：2006-02-03
申请人： Jong Soo Woo , Hong Gi Yi , Jeong Hee Park
发明人： Jong Soo Woo , Hong Gi Yi , Jeong Hee Park
IPC分类号： A61K31/4353 , A61P43/00
CPC分类号： C07D498/18 , A61K9/1617 , A61K9/1623 , A61K9/1635 , A61K9/1641 , A61K9/1652 , A61K9/4858 , A61K9/4866 , A61K31/436
摘要： An amorphous taclolimus solid dispersion comprising taclolimus, a substituted cyclodextrin derivative and an organic acid, which has a high thermodynamic stability and solubility, can provide an enhanced release rate and bioavailability.
摘要翻译：包含具有高热力学稳定性和溶解性的三氯意大利溶剂，取代环糊精衍生物和有机酸的无定形taclolimus固体分散体可以提供增强的释放速率和生物利用度。

28. 发明授权

US06706285B1 Enteric coated formulation of a benzimidazole derivative and method for preparation thereof 有权
标题翻译：苯并咪唑衍生物的肠溶包衣制剂及其制备方法
公开(公告)号：US06706285B1
公开(公告)日：2004-03-16
申请号：US09357570
申请日：1999-07-20
申请人： Jong Soo Woo
发明人： Jong Soo Woo
IPC分类号： A61K914
CPC分类号： A61K9/5042 , A61K9/2866 , A61K31/4439 , A61K47/585
摘要： Disclosed are an enteric coated formulation of a benzimidazole derivative comprising a core and a film of an enteric coating agent on the surface thereof, the core containing a complex of the benzimidazole derivative and an ion-exchange resin, and the enteric coating agent having the degree of substitution by an acidic group of less than 30%, and a method for preparation thereof.
摘要翻译：本发明公开了一种苯并咪唑衍生物的肠溶包衣制剂，其包含核心和其表面上的肠溶衣的膜，所述核心包含苯并咪唑衍生物和离子交换树脂的复合物，以及具有度的低于30％的酸性基团的取代基及其制备方法。

29. 发明授权

US5639474A Cyclosporin soft capsule composition 失效
标题翻译：环孢菌素软胶囊组合物
公开(公告)号：US5639474A
公开(公告)日：1997-06-17
申请号：US427465
申请日：1995-04-24
申请人： Jong Soo Woo
发明人： Jong Soo Woo
IPC分类号： A61K38/13 , A61K9/10 , A61K9/48
CPC分类号： B82Y5/00 , A61K38/13 , Y10S514/885 , Y10S514/937 , Y10S514/962 , Y10S514/97 , Y10S514/975
摘要： The present invention relates to a microemulsion concentrate containing cyclosporin as an active ingredient, dimethylisosorbide as a cosurfactant, oil and a surfactant which is suitable for the formulation of a soft capsule for oral administration, said cyclosporin, dimethyl isosorbide, oil and surfactant being present in the ratio of 1:1-5:1-5:2-10, and preferably in the ratio of 1:2-4:2-5:2-4:7, by weight. Since dimethylisosorbide has substantially no membrane permeation property, the soft capsule preparation according to the present invention is outstandingly stable in comparison with the soft capsules containing ethanol, propylene glycol, transcutol, glycofurol, etc., as a cosurfactant in the prior art, and further provides an advantage in that the pharmaceutical effect, appearance and composition content of the soft capsule according to the present invention are not changed.
摘要翻译：本发明涉及含有环孢菌素作为活性成分的微乳液浓缩物，二甲基异山梨醇作为辅助表面活性剂，油和表面活性剂，其适用于配制口服软胶囊，所述环孢菌素，二甲基异山梨醇，油和表面活性剂存在于 1：1-5：1-5：2-10的比例，优选的比例为1：2-4：2-5：2-4：7。由于二甲基异山梨醇基本上没有膜渗透性，因此与现有技术中作为辅助表面活性剂的乙醇，丙二醇，吡咯醇，糖醇等软胶囊相比，本发明的软胶囊制剂显着稳定提供了根据本发明的软胶囊的药物作用，外观和组合物含量不改变的优点。

30. 发明申请

US20100233261A1 Pharmaceutical Composition Comprising Amlodipine and Losartan 审中-公开
标题翻译：药物组合物包含氨氯地平和氯沙坦
公开(公告)号：US20100233261A1
公开(公告)日：2010-09-16
申请号：US12303034
申请日：2007-12-07
申请人： Jong Soo Woo , Hong Gi Yi , Moon Hyuk Chi , Kyeong Soo Kim
发明人： Jong Soo Woo , Hong Gi Yi , Moon Hyuk Chi , Kyeong Soo Kim
IPC分类号： A61K9/30 , A61K31/455 , A61K9/00 , A61K9/20 , A61P9/00 , A61P9/10 , A61P9/12
CPC分类号： A61K31/44 , A61K9/2077 , A61K9/209 , A61K31/4178 , A61K31/4422 , A61K2300/00
摘要： Disclosed herein is a pharmaceutical composition comprising a part containing amlodipine or a pharmaceutically acceptable salt thereof and another separate part containing losartan or a pharmaceutically acceptable salt thereof, which exhibits improved preventive and therapeutic effects against cardiovascular disorders.
摘要翻译：本文公开了一种药物组合物，其包含含有氨氯地平或其药学上可接受的盐的部分和含有氯沙坦或其药学上可接受的盐的另一部分，其对心血管疾病具有改进的预防和治疗作用。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式